Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperammonemia-induced toxicity for the developing central nervous system.

Laurène Cagnon1, Olivier Braissant

  • 1Clinical Chemistry Laboratory, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CI 02/33, Avenue Pierre-Decker 2, CH-1011 Lausanne, Switzerland.

Brain Research Reviews
|September 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-time monitoring of cell culture contamination via TVOC and gas sensing technologies.

Talanta·2025
Same author

Efficacy of a commercial bacteriophage cocktail against planktonic cells and both thin and thick biofilms of skin pathogens, measured using isothermal microcalorimetry.

Frontiers in microbiology·2025
Same author

Heterozygous females from a rat model for creatine transporter deficiency reveal altered behavioral response to stressors, normal body weight and slight metabolic changes.

Frontiers in neuroscience·2025
Same author

Correction: Schicklin et al. Method to Generate Chlorine Dioxide Gas In Situ for Sterilization of Automated Incubators. <i>Pathogens</i> 2024, <i>13</i>, 1024.

Pathogens (Basel, Switzerland)·2025
Same author

Evaluation of Antimicrobial Performance of Calcium Dihydroxide (Ca(OH)<sub>2</sub>) Coating on Ti for Potential Metallic Orthopedic Implant Applications.

Antibiotics (Basel, Switzerland)·2025
Same author

Diagnostic delay in cerebral creatine deficiency disorders: lessons learned from a cross-sectional single center study, and guanidinoacetate and creatine measurements in Switzerland between 2015 and 2023.

Molecular and cellular pediatrics·2025

Hyperammonemia causes irreversible brain damage in children by affecting amino acid pathways and energy metabolism. New research reveals molecular mechanisms and potential neuroprotective strategies for congenital hyperammonemia.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pediatric Neurology

Background:

  • Hyperammonemia in pediatric patients stems from inherited or acquired disorders like urea cycle deficiencies.
  • The developing brain is highly vulnerable to ammonium's toxic effects, leading to irreversible damage such as cognitive impairment and seizures.
  • Mechanisms underlying these neurotoxic effects were previously unclear.

Purpose of the Study:

  • To investigate the molecular mechanisms of ammonium neurotoxicity in the developing brain.
  • To identify key pathways and cellular processes affected by hyperammonemia.
  • To explore potential neuroprotective strategies.

Main Methods:

  • Utilized experimental models to analyze ammonium's neurotoxic effects on the developing brain.

Related Experiment Videos

  • Examined alterations in amino acid pathways, neurotransmitter systems, and cerebral energy metabolism.
  • Investigated effects on nitric oxide synthesis, oxidative stress, and signal transduction.

    • Main Results:

    • Ammonium exposure disrupts amino acid pathways, neurotransmitter systems, and cerebral energy metabolism.
    • Observed alterations in nitric oxide synthesis, oxidative stress, and mitochondrial function.
    • Identified neuronal loss and impaired axonal/dendritic growth in congenital hyperammonemia models.

    Conclusions:

    • Ammonium toxicity involves multiple molecular pathways impacting neuronal function and development.
    • Potential neuroprotective agents include NMDA receptor antagonists, nitric oxide inhibitors, creatine, and acetyl-l-carnitine.
    • Understanding these mechanisms is crucial for developing novel neuroprotection strategies for hyperammonemia.